Biosurgicals and the Minimally Invasive Gynecologic Surgery (MIGS) Surgeon

Abstract:

Biosurgical materials (biosurgicals) have a wide array of uses for providing hemostasis, including decreasing the risk of postoperative bleeding and, intraoperatively, controling bleeding. These materials are especially useful in situations where electrocautery, sutures, or clips are not feasible. Biosurgicals have long been used in general surgery and surgical subspecialties to provide hemostasis; however, they still are not commonly used during obstetric and gynecologic procedures. Three commonly used classes of biosurgicals will be discussed in this article: oxidized regenerated cellulose, flowables, fibrin sealants, and fibrin sealant patches. Each of these agents has a different role to play during minimally invasive gynecologic surgery (MIGS), either singularly or in combination with each other. One unique fibrin product is a fibrin sealant patch, which is a combination of products used to treat bleeding of various intensities, including acute, severe hemorrhagic situations. It is important for the MIGS surgeon to understand the nature and use of each product to be able to use biosurgicals appropriately for hemostasis management. This article reviews biosurgical products, their composition, and application in minimally invasive gynecologic surgery. Included will be a few of the "on label" and "off-label" uses of biosurgicals—either singularly or in combination—and tips for introducing these materials during MIGS procedures.

Authors:

James Dana Kondrup, MD, Assistant Clinical Professor, Obstetrics and Gynecology Department, Upstate Medical Center, Binghamton Campus, Binghamton, New York, Frances R. Anderson, PhD, RN, Research Coordinator, Nursing Administration, Our Lady of Lourdes Memorial Hospital, Binghamton, New York, Melanie Rose Katz, MS IV, Medical Student, SUNY Upstate Medical Center, Syracuse, New York

For Direct IP Access please click this link